RECOMBIVAX HB
RECOMBIVAX HB Hepatitis B Vaccine (Recombinant) is a sterile suspension of non-infectious subunit viral vaccine derived from HBsAg produced in yeast cells.
Indications: For prevention of infection caused by all known subtypes of hepatitis B virus.
Manufacturing Platform:
12/21/2018 – FDA approval date